Public procurement notice: Modification Of A Contract/Concession During Its Term
Published: 2020-04-22
Buyer: NHS Blood and Transplant
Country: UK
Contract type: Supplies
CPV classification: 33140000: Medical consumables | 33621400 | 33692400

Technical requirements: NHS Blood and Transplant (the Authority) is the commissioner responsible for providing funding, infrastructure, clinical guidance and standards to the National Organ Retrieval Service (NORS). NORS is comprised of several organ retrieval teams (Teams) based at a range of transplant centres in England, Wales and Scotland. The authority has a contract in place with each NORS team, for the provision of organ retrieval services. The teams purchase their own consumables and are reimbursed each financial quarter by the Authority.
Covid-19 pandemic is a novel, unprecedented situation that NHSBT could not have forseen at the time it awarded the contract. ODT departament is unable to focus on preparing the procurement excercise due to staff being diverted by urgent actions to deal with COVID-19 consequences and staff being redeployed. According to the recent developments a new tender perfusion fluid solution is now due to be issued in summer 2020.
Due to the pandemic situation NHSBT agreed with all current suppliers and potential bidders (as identified via the PIN 2019/S 040-089561) that the current supply of of Lot 1 (Bridge to Life Ltd) in NHSBT0666 to extend this existing agreement beyond 1 July 2020 by 4 months (to 1 November 2020).
Total value of increase in price does not exceed 50 % of the value of the original framework agreement; The nature of contract has not been changed.
Covid-19 pandemic is a novel, unprecedented situation that NHSBT could not have forseen at the time it awarded the contract. ODT department is unable to focus on preparing the procurement excercise due to staff being diverted by urgent actions to deal with Covid-19 consequences and staff being redeployed.
NHS Blood and Transplant (the Authority) is the commissioner responsible for providing funding, infrastructure, clinical guidance and standards to the National Organ Retrieval Service (NORS). NORS is comprised of several organ retrieval teams (Teams) based at a range of transplant centres in England, Wales and Scotland. The Authority has a contract in place with each NORS team, for the provision of organ retrieval services. The teams purchase their own consumables and are reimbursed each financial quarter by the Authority.
Covid-19 pandemic is a novel, unprecedented situation that NHSBT could not have forseen at the time it awarded the contract. ODT department is unable to focus on preparing the procurement excercise due to staff being diverted by urgent actions to deal with Covid-19 consequences and staff being redeployed. According to the recent developments a new tender perfusion fluid solution is now due to be issued in summer 2020.
Due to the pandemic situation NHSBT agreed with all current suppliers and potential bidders (as identified via the PIN 2019/S 040-089561) that the current supply of of Lot 1 (Bridge to Life Ltd) in NHSBT0666 to extend this existing agreement beyond 1 July 2020 by 4 months (to 1 November 2020).
Total value of increase in price does not exceed 50 % of the value of the original framework agreement; The nature of contract has not been changed.
Covid-19 pandemic is a novel, unprecedented situation that NHSBT could not have forseen at the time it awarded the contract. ODT department is unable to focus on preparing the procurement excercise due to staff being diverted by urgent actions to deal with Covid-19 consequences and staff being redeployed. Total value of increase in price does not exceed 50 % of the value of the original framework
Due to the pandemic situation NHSBT agreed with all current suppliers and potential bidders (as identified via the PIN 2019/S 040-089561) that the current supply of of Lot 1 (Bridge to Life Ltd) in NHSBT0666 to extend this existing agreement beyond 1 July 2020 by 4 months (to 1 November 2020).
Covid-19 pandemic is a novel, unprecedented situation that NHSBT could not have forseen at the time it awarded the contract. ODT department is unable to focus on preparing the procurement excercise due to staff being diverted by urgent actions to deal with Covid-19 consequences and staff being redeployed. According to the recent developments a new tender perfusion fluid solution is now due to be issued in summer 2020.


Winner: Bridge to Life (Europe) Ltd